Drugs For Diabetes
- All
- News
- Videos
-
Weight Loss Drugs In India: The Rise Of GLP-1s In 2025
GLP-1 receptor agonists mimic the action of the glucagon-like peptide-1 hormone, which is involved in the regulation of appetite and insulin secretion. When administered, these medications stimulate insulin production.
-
Ozempic May Lower Risk Of Epilepsy In Diabetes Patients, New Study Finds
The study offers early evidence of neurological benefits from these diabetes and weight loss medications.
-
Ozempic Enters India: Diabetes Drug, Not A Miracle Fix, Novo Nordisk MD To NDTV
In an exclusive interaction with NDTV, Managing Director of Novo Nordisk India, Vikrant Shrotriya, said the launch of injectable semaglutide marks a significant moment for diabetes treatment.
-
Who Should Avoid Ozempic? Doctor Explains Why The Drug Is Not For Everyone
Ozempic can be beneficial for a lot of people, however, some people should avoid it. Read on to know why the drug is not for everyone.
-
Can Non-Diabetics Take Ozempic For Weight Loss? Doctor Answers
Ozempic is the brand name for a medication called semaglutide, which is primarily used to manage type 2 diabetes. It belongs to a class of drugs known as GLP-1 receptor agonists
-
What Is Ozempic Neck? Causes, Signs And Can You Prevent It?
"Ozempic neck" is a popular term used to describe visible neck sagging, wrinkles or lax skin that some people report after rapid weight loss from Ozempic.
-
Ozempic Injection Price In India: How Affordable Is It For Diabetes And Weight Loss?
Ozempic, a once-weekly semaglutide injection for type-2 diabetes, has debuted in India with pricing starting at roughly Rs 2,200 per week.
-
Ozempic Launched In India: Doctors Welcome New Diabetes Drug, Warn Against Misuse For Weight Loss
Doctors highlight that the drug should be administered along with a healthy diet and regular exercise for management of type 2 diabetes, and not just as cosmetic procedure for weight loss.
-
Diabetes, Weight Loss Drug Ozempic Launched In India: See Dosage, Price And More
Novo Nordisk on Friday launched its blockbuster weight-loss drug Ozempic in India, beginning at Rs 8,800 a month or four weeks.
-
"Medication Alone Won't Reverse Obesity": WHO Issues Guidelines On GLP-1 Drugs
The WHO guideline emphasises that medicines alone will not solve the problem.Addressing obesity requires a comprehensive approach.
-
Cholesterol: These Desi Foods Can Help Manage Your Levels
Keep reading as we discuss how some traditional Indian ingredients that can play a role in keeping cholesterol in check.
-
This Inexpensive, Easily Available Drug Offers Hope For Diabetic Kidney Disease, Finds Study
Diabetes is now the leading cause of CKD in India. A new study found that Levocetirizine can help in the management of kidney disease.
-
Novo Nordisk Partners With Emcure To Launch Weight Loss Drug Poviztra In India
Emcure Pharma becomes the first Indian company to hold exclusive rights to distribute and commercialise Poviztra, a semaglutide injection 2.4 mg for weight loss, the statement said.
-
Some Diabetes Patients Achieve Remission With GLP-1 Drugs: Italian Study
An Italian study shows that using GLP-1 receptor agonists can lead to remission in up to 18% of cases, especially when used early and in patients with fewer complications.
-
Ozempic Is Here In India But It's Not A Magic Weight Loss Pill, Says Nutritionist
Ozempic arrives in India, but nutritionist Nmami Agarwal encourages reasonable expectations amid the hype.
-
Weight Loss Drugs In India: The Rise Of GLP-1s In 2025
GLP-1 receptor agonists mimic the action of the glucagon-like peptide-1 hormone, which is involved in the regulation of appetite and insulin secretion. When administered, these medications stimulate insulin production.
-
Ozempic May Lower Risk Of Epilepsy In Diabetes Patients, New Study Finds
The study offers early evidence of neurological benefits from these diabetes and weight loss medications.
-
Ozempic Enters India: Diabetes Drug, Not A Miracle Fix, Novo Nordisk MD To NDTV
In an exclusive interaction with NDTV, Managing Director of Novo Nordisk India, Vikrant Shrotriya, said the launch of injectable semaglutide marks a significant moment for diabetes treatment.
-
Who Should Avoid Ozempic? Doctor Explains Why The Drug Is Not For Everyone
Ozempic can be beneficial for a lot of people, however, some people should avoid it. Read on to know why the drug is not for everyone.
-
Can Non-Diabetics Take Ozempic For Weight Loss? Doctor Answers
Ozempic is the brand name for a medication called semaglutide, which is primarily used to manage type 2 diabetes. It belongs to a class of drugs known as GLP-1 receptor agonists
-
What Is Ozempic Neck? Causes, Signs And Can You Prevent It?
"Ozempic neck" is a popular term used to describe visible neck sagging, wrinkles or lax skin that some people report after rapid weight loss from Ozempic.
-
Ozempic Injection Price In India: How Affordable Is It For Diabetes And Weight Loss?
Ozempic, a once-weekly semaglutide injection for type-2 diabetes, has debuted in India with pricing starting at roughly Rs 2,200 per week.
-
Ozempic Launched In India: Doctors Welcome New Diabetes Drug, Warn Against Misuse For Weight Loss
Doctors highlight that the drug should be administered along with a healthy diet and regular exercise for management of type 2 diabetes, and not just as cosmetic procedure for weight loss.
-
Diabetes, Weight Loss Drug Ozempic Launched In India: See Dosage, Price And More
Novo Nordisk on Friday launched its blockbuster weight-loss drug Ozempic in India, beginning at Rs 8,800 a month or four weeks.
-
"Medication Alone Won't Reverse Obesity": WHO Issues Guidelines On GLP-1 Drugs
The WHO guideline emphasises that medicines alone will not solve the problem.Addressing obesity requires a comprehensive approach.
-
Cholesterol: These Desi Foods Can Help Manage Your Levels
Keep reading as we discuss how some traditional Indian ingredients that can play a role in keeping cholesterol in check.
-
This Inexpensive, Easily Available Drug Offers Hope For Diabetic Kidney Disease, Finds Study
Diabetes is now the leading cause of CKD in India. A new study found that Levocetirizine can help in the management of kidney disease.
-
Novo Nordisk Partners With Emcure To Launch Weight Loss Drug Poviztra In India
Emcure Pharma becomes the first Indian company to hold exclusive rights to distribute and commercialise Poviztra, a semaglutide injection 2.4 mg for weight loss, the statement said.
-
Some Diabetes Patients Achieve Remission With GLP-1 Drugs: Italian Study
An Italian study shows that using GLP-1 receptor agonists can lead to remission in up to 18% of cases, especially when used early and in patients with fewer complications.
-
Ozempic Is Here In India But It's Not A Magic Weight Loss Pill, Says Nutritionist
Ozempic arrives in India, but nutritionist Nmami Agarwal encourages reasonable expectations amid the hype.
